Scroll Back to Top
Accessibility
Accessibility
GettyImages-1585065585.jpg

LABCORP NGS PANELS

Improving outcomes for patients with hematologic malignancies

Labcorp Myeloid NGS, Labcorp Lymphoid NGS and Labcorp Pan-Heme NGS are next generation sequencing (NGS) assays that evaluate clinically relevant genes to deliver diagnoses and risk stratification for complex hematologic malignancies.

Get in Touch
supporting image

Powering Better Decisions

Labcorp NGS Panels help identify gene alterations that have diagnostic, prognostic and therapeutic significance in patients with myeloid and lymphoid malignancies.

Labcorp Myeloid NGS Panel

To aid in diagnosis, prognostic risk assessment, and therapeutic selection in myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN)

Labcorp Lymphoid NGS Panel

To aid in diagnosis, prognostic risk assessment, and therapeutic selection in lymphoid malignancies, including lymphoblastic leukemias (B-ALL/T-ALL), CLL (chronic lymphocytic leukemia), DLBCL, mantle cell lymphoma, follicular lymphoma, T cell lymphoma, hairy cell leukemia and other lymphoma subtypes

Labcorp Pan-Heme NGS Panel

To aid in diagnosis, prognostic risk assessment, and therapeutic selection in various myeloid and lymphoid malignancies

How to Order Labcorp NGS Panels Brochure Labcorp NGS Panels Gene List

Gene List   |  Patient Reports  |  Sample Requirements

NGS panels

Labcorp Myeloid NGS [452312] (50 genes)
ANKRD26BRAFCUX1EZH2IDH1JAK3NF1PPM1DSETBP1TP53
ASXL1CALRDDX41FLT3IDH2KITNPM1PRPF8SF3B1U2AF1
ATRXCBLDNMT3AGATA1IKZF1KMT2ANRASPTPN11SRSF2UBA1
BCORCEBPAETNK1GATA2IL7RKRASPHF6RAD21STAG2WT1
BCORL1CSF3RETV6GNB1JAK2MPLPIGARUNX1TET2ZRSR2
Labcorp Lymphoid NGS [452332] (50 genes)
ARID1ABRAFCD79BEP300IRF4MAP2K1NOTCH2PLCG2SOCS1TET2
ATMBTKCDKN2AEZH2JAK1MEFB2NRASPRDM1STAT3TNFAIP3
B2M CARD11CREBBPFBXW7JAK3MYCNSD2RHOASTAT5BTNFRSF14
BCL2CCND1CXCR4FOXO1KRASMYD88PIK3CDSETD2STAT6TP53
BIRC3CCND3DNMT3AIDH2MAPK1NOTCH1PIM1SF3B1TCF3XPO1
Labcorp Pan-Heme NGS [452322] (141 genes)
ABL1CALRCIITAERGHRASMAPK1P2RY8PRDM1SH2B3TP53
ANKRD26CARD11CREBBPETNK1IDH1MAP2K1PAX5PRPF8SMC1AU2AF1
ARID1ACBLCRLF2ETV6IDH2MED12PDCD1PTENSMC3UBA1
ASXL1CBLBCSF1REVH2IKZF1MEFB2PDGFRAPTPN11SOCS1WT1
ATMCBLCCSF3RFASIKZF3MPLPHF6RAD21SRSF2XPO1
ATRXCCND1CSNK1A1FBXW7IL7RMYCPIGARB1STAG2ZRSR2
B2MCCND3CTCFFGFR1IRF4MYD88PIK3CARHOASTAT3 
BCL2CD274CUX1FGFR3JAK1NF1PIK3CDRIT1STAT5B 
BCL6 CD79ACXCR4FLT3JAK2NFE2PIK3CGRUNX1STAT6 
BCORCD79BDDX41FOXO1JAK3NOTCH1PIK3R1SAMD9TCF3 
BCORL1CDK4DKC1GATA1KDM6ANOTCH2PIM1SAMD9LTERC 
BIRC3CDKN1BDNMT3AGATA2KITNPM1PLCG2SBDSTERT 
BRAFCDKN2AEBF1GNA13KMT2ANRASPMLSETBP1TET2 
VRCC3CDKN2BELANEGNASKRASNSD2POT1SETD2TNFAIP3 
BTKCEBPAEP300GNB1MALT1NT5C2PPM1DSF3B1SNFRSF14 

Note: Whole gene copy number variants detected in bold. Exon level (two or more exons) copy number analysis for IKZF1, KMT2A, RUNX1, TET2, TP53

Patient Reports: Concise, Comprehensive & Actionable
 

Comprehensive Quick-Read Results

Gain actionable insights at a glance with:

  • Clinically significant results
  • Therapy implications summary
  • Personalized interpretation for each variant

THERAPEUTIC IMPLICATIONS

Start to formulate a plan with:

  • FDA-approved therapies
  • Possible drug resistance information
  • Clinical trial information for each variant

PERSONALIZED INTERPRETATION:

Expand your patient’s options with:

  • Diagnostic, prognostic and therapeutic significance
  • Clinical trial matches for each variant
  • Easy access to available trial information
Expand
Sample requirements

Please provide a clinical indication or related ICD-10 code on the test requisition form

Specimen type:  Bone marrow aspirate, peripheral blood, cell suspension from fresh tissue and Formalin-fixed, paraffin-embedded (FFPE) (for Labcorp Lymphoid NGS and Labcorp Pan-Heme NGS Panels)

Volume:  3-5ml (whole blood); 1-2ml (bone marrow); formalin-fixed, paraffin-embedded (FFPE) tissue block or 10 unstained slides and one matching H&E-stained slide at 5µm. Slides with a tissue area of 50mm2 are preferred; minimum area 2mm2.

Container:  Lavender-top (EDTA) tube or green-top (heparin) tube

Turnaround time: Blood and bone marrow: 10-14 days; FFPE: 14-21 days

For additional test information, please visit the test menu page

lab-coat.svg

High Laboratory Quality Standards

  • NYS CLEP approved
  • CLIA and CAP accredited

Note: Panels accepting FFPE specimen types are not NYS CLEP approved

coverage.svg

Labcorp Broad National Coverage

  • In-network with most major health plans

To learn more, please contact us

Contact us